Metabolic impact of oral contraceptives with or without metformin in obese adolescents with polycystic ovary syndrome (PCOS)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary) ; Drospirenone/ethinylestradiol; Ethinylestradiol/desogestrel; Oral contraceptives
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 15 May 2015 Biomarkers information updated
- 12 Jul 2011 Actual initiation date (Jan 2006) added as reported by ClinicalTrials.gov.
- 11 Oct 2006 New trial record.